109235 ⎘
Production Biochemical production, i.e. in a transformed host cell
Sub-classes:PLANT REGULATORY ELEMENTS AND USES THEREOF
#2COMPOSITIONS AND THERAPEUTIC METHODS OF MICRORNA GENE DELIVERY
#3SEQUENCE DETERMINANTS OF DSRNA PROCESSING BY DICER
#4MOLECULAR PROGRAMMING TOOLS
#5METHODS AND COMPOSITIONS FOR NON-MYELOABLATIVE BONE MARROW RECONSTITUTION
#6OPTIMIZED SEQUENCES FOR ENHANCED tRNA EXPRESSION OR/AND NONSENSE MUTATION SUPPRESSION
#7MODULATORY POLYNUCLEOTIDES
#8METHOD FOR ANALYZING BY-PRODUCTS OF RNA IN VITRO TRANSCRIPTION
#9METHOD FOR SILENCING GENES
#10AGENT FOR USE IN THE TREATMENT OF GLIOMA
#11CHLORELLA-BASED PRODUCTION OF EXTRACELLULAR VESICLE-EMBEDDED SMALL RNAS FOR BIOCONTROL APPLICATIONS
#12PLANT REGULATORY ELEMENTS AND USES THEREOF
#13COMPOSITIONS AND THERAPEUTIC METHODS OF MICRORNA GENE DELIVERY
#14GENOME EDITING USING EFFECTOR OLIGONUCLEOTIDES FOR THERAPEUTIC TREATMENT
#15COMPOSITIONS AND METHODS FOR TREATING CEP290 ASSOCIATED DISEASE
#16METHODS AND COMPOSITIONS FOR TREATING EPILEPSY
#17METHODS AND COMPOSITIONS FOR INCREASED DOUBLE STRANDED RNA PRODUCTION
#18Modified DAAO enzyme and application thereof
#19COMPOSITIONS AND MULTIPLEXED SYSTEMS FOR COUPLED CELL-FREE TRANSCRIPTION-TRANSLATION AND PROTEIN SYNTHESIS AND METHODS FOR USING THEM
#20COMPOSITIONS AND METHODS FOR REGULATING PRODUCTION OF AN EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR
#21SYSTEMS AND METHODS FOR TRANSPOSING CARGO NUCLEOTIDE SEQUENCES
#22Treatment delivery system and method
#23SMALL RNA MEDICAMENT FOR PREVENTION AND TREATMENT OF INFLAMMATION-RELATED DISEASES AND COMBINATION THEREOF
#24METHODS AND COMPOSITIONS FOR SELECTIVE PCR AND CLONING OF ANTIBODY SEQUENCES
#25Noscapinoid-producing Microbes and Methods of Making and Using the Same
#26CELLS AND METHODS FOR PRODUCING METHYL KETONES
#27CELL-FREE GLYCOPROTEIN SYNTHESIS (CFGPS) IN PROKARYOTIC CELL LYSATES ENRICHED WITH COMPONENTS FOR GLYCOSYLATION
#28BACTERIAL CELLS WITH IMPROVED TOLERANCE TO DIACIDS
#29HAIRPIN LOOP ENDED SELF-COMPLEMENTARY DOUBLE-STRANDED COVALENTLY CLOSED LINEAR DNA VECTOR, MANUFACTURING SYSTEM AND PROCESS, AND USES OF SAID RESULTING DNA VECTOR
#30METHOD FOR PREPARING MRNA-GALNAC TARGETING MOLECULE, IN VIVO DELIVERY SYSTEM THEREFOR, AND USE THEREOF
#31IMPROVED GENOME EDITING USING PAIRED NICKASES
#32METHOD FOR THE PRODUCTION OF RAAV AND METHOD FOR THE IN VITRO GENERATION OF GENETICALLY ENGINEERED, LINEAR, SINGLE-STRANDED NUCLEIC ACID FRAGMENTS CONTAINING ITR SEQUENCES FLANKING A GENE OF INTEREST
#33Compositions and method of making a complex able to increase production of a cetuximab-like protein (CLP) in a target cell
#34Molecular programming tools
#35Modified DAAO enzyme and application thereof
#36RECOMBINANT VECTOR FOR HIGH-EXPRESSION OF PROTEINS IN YEASTS
#37ANTIMICROBIAL ENDOLYSIN POLYPEPTIDES, COMPOSITIONS AND FORMULATIONS
#38OXIDATION-RESISTANT SERPINS
#39METHOD FOR CONTROLLING MICRORNA EXPRESSION
#40Agent for use in the treatment of glioma
#41Methods and compositions for increased double stranded RNA production
#42Modulatory polynucleotides
#43TREM COMPOSITIONS AND USES THEREOF
#44RNA POLYMERASE FOR SYNTHESIS OF MODIFIED RNA
#45INHIBITORS OF CACNA1A/ALPHA1A SUBUNIT INTERNAL RIBOSOMAL ENTRY SITE (IRES) AND METHODS OF TREATING SPINOCEREBELLAR ATAXIA TYPE 6
#46Methods for measuring and improving CRISPR reagent function
#47PD-L1 binding polypeptides for imaging
#48METHODS OF REFINING A GRAIN OIL COMPOSITION, AND RELATED SYSTEMS, COMPOSITIONS AND USES
#49Compositions and therapeutic methods of microRNA gene delivery
#50Plant regulatory elements and uses thereof
#51METHODS AND COMPOSITIONS FOR EDITING RNAS
#52Compositions and methods for evading bacterial defense mechanisms
#53USING MICRORNAS TO CONTROL ACTIVATION STATUS OF HEPATIC STELLATE CELLS AND TO PREVENT FIBROSIS IN PROGRESSIVE LIVER DISEASES
#54RNA/DNA HYBRID NANOPARTICLES MODIFIED WITH SINGLE STRANDED RNA TOEHOLDS AND USES THEREOF
#55METHOD FOR PRODUCING SINGLE-STRAND RNA
#56Mutant MYC fusion polypeptides and uses thereof
#57Genome editing using effector oligonucleotides for therapeutic treatment
#58Compositions and methods for treating HIF-1a over-expressing cancers
#59Concatemeric RNA molecules, compositions, and methods and uses thereof
#60Method for manufacturing protein
#61Modulatory polynucleotides
#62NUCLEIC ACIDS COMPRISING IMPREFECT HAIRPINS
#63Use of an esterase to enhance ethyl ester content in fermentation media
#64COMPOSITION AND METHOD OF USING MIR-302 PRECURSORS AS ANTI-CANCER DRUGS FOR TREATING HUMAN LUNG CANCER
#65Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
#66CELLS WITH IMPROVED PENTOSE CONVERSION
#67Anti-CXCR4 antibodies and antibody-drug conjugates
#68Inhibitors of CACNA1A/ALPHA1A subunit internal ribosomal entry site (IRES) and methods of treating spinocerebellar ataxia type 6
#69PD-L1 binding polypeptides for imaging
#70Compositions for in vivo Expression of Therapeutic Sequences in the Microbiome
#71Methods for non-myeloablative bone marrow reconstitution
#72Method for producing objective substance
#73Compositions and methods for brown fat induction and activity using FNDC5
#74Cells with improved pentose conversion
#75Compositions and methods for treating CEP290 associated disease
#76Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
#77Using microRNAs to control activation status of hepatic stellate cells and to prevent fibrosis in progressive liver diseases
#78Molecular programming tools
#79Methods and compositions for increased double stranded RNA production
#80In-vitro induction of adult stem cell expansion and derivation
#81INHIBITING GENE EXPRESSION WITH dsRNA
#82Use of an esterase to enhance ethyl ester content in fermentation media
#83METHOD FOR PREPARING RECOMBINANT PROTEINS THROUGH REDUCTION OF rnpA GENE EXPRESSION
#84Methods and compositions for modulating AAV infection
#85Variants of chymosin with improved milk-clotting properties
#86Method and System for Monitoring Nutritional Uptake as a Function of Hydrogen Gas Levels
#87Cell-free glycoprotein synthesis (CFGpS) in prokaryotic cell lysates enriched with components for glycosylation
#88Glucan kinases and methods for processing starch using the same
#89Methods and compositions for the production of siRNAs
#90METHODS AND COMPOSITIONS COMPRISING APSE KNOTS
#91COMPOSITIONS AND MULTIPLEXED SYSTEMS FOR COUPLED CELL-FREE TRANSCRIPTION-TRANSLATION AND PROTEIN SYNTHESIS AND METHODS FOR USING THEM
#92Agents for use in the treatment of glioma
#93BIOLOGICAL METHODS FOR PREPARING 3-HYDROXYPROPIONIC ACID
#94Methods and compositions for enhancing the therapeutic effect of anti-tumor T cells
#95Small-interfering RNA expression systems for production of small-interfering RNAs and their use
#96Human antibody specific for interleukin-1 alpha
#97Cell engineering using MICRORNAs
#98Therapeutic methods, products and compositions inhibiting ZNF555
#99Polynucleotides encoding anti-Notch1 NRR antibody polypeptides
#100Method of packing polynucleotides
#101Glycaspis Brimblecombei Control Agents
#102Compositions and methods using capsids resistant to hydrolases
#103Method for improving heterologous synthesis of into polyketides and use of same
#104Inflammatory disease diagnosis and methods of treatment using down-regulators of lipopolysaccharide-responsive beige-like anchor
#105Viral RNA segments as immunomodulatory agents and vaccine components
#106Method for preparing recombinant proteins through reduction of rnpA gene expression
#107USE OF MICRORNA PRECURSORS AS DRUGS FOR INDUCING CD34-POSITIVE ADULT STEM CELL EXPANSION
#108Preventing and treating inflammatory skin diseases
#109Modulatory polynucleotides
#110Methods for characterizing alternatively or aberrantly spliced mRNA isoforms
#111NOSCAPINOID-PRODUCING MICROBES AND METHODS OF MAKING AND USING THE SAME
#112Composition and method of using miR-302 precursors as anti-cancer drugs for treating human lung cancer
#113INHIBITING GENE EXPRESSION WITH dsRNA
#114Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
#115EXTRACELLULAR VESICLE METHODS AND COMPOSITIONS
#116Compositions and methods for treating hepatitis B
#117Double-stranded and single-stranded RNA molecules with 5′ triphosphates and their use for inducing interferon
#118Compositions for in vivo expression of therapeutic sequences in the microbiome
#119Synthesis of transcripts using Syn5 RNA polymerase
#120Double-stranded polyC:poly(G/I) RNA for immunostimulation and cancer treatment
#121Use of microRNA precursors as drugs for inducing CD34-positive adult stem cell expansion
#122Biological control of insects
#123Use of novel monosaccharide-like glycylated sugar alcohol compositions for designing and developing anti-diabetic drugs
#124Targeting non-coding RNA for RNA interference
#125Therapeutic phages and methods for delivery of nucleic acids for therapeutic uses
#126Inflammatory disease diagnosis and methods of treatment using lipopolysaccharides-responsive beige-like anchor
#127Methods and compositions for enhancing the therapeutic effect of anti-tumor T cells
#128Antiproliferative agent
#129Compositions and methods for treating HIF-1α over-expressing cancers
#130Genome editing using effector oligonucleotides for therapeutic treatment
#131Recombinant polypeptide production
#132Human antibody specific for interleukin-1alpha
#133Method of producing dicer
#134Plants as functional microRNA and/or functional siRNA carriers, preparation methods and uses thereof
#135Methods and compositions for the production of siRNAs
#136Use of monosaccharide-like glycylated sugar alcohol compositions for designing and developing anti-diabetic drugs
#137Co-transcriptional assembly of modified RNA nanoparticles
#138Oral delivery of nucleic acid-based gene interfering agents by
#139Variants of chymosin with improved milk-clotting properties
#140Methods, systems, and compositions for cell-derived/vesicle-based microrna delivery
#141Expression Construct for a Lin28-Resistant Let-7 Precursor MicroRNA
#142Method of reducing the number of EMT and MET type breast cancer stem cells
#143Methods and compositions for the treatment of insulin-associated medical conditions
#144Targeted and modular exosome loading system
#145Bronze bug control agents
#146Compositions for RNA interference and methods of use thereof
#147SINGLE-STRANDED ANTIMICROBIAL OLIGONUCLEOTIDES AND USES THEREOF
#148Sugar alcohol-based compositions for delivering nucleic acid-based drugs in vivo and in vitro
#149Targeting CLPTM1L by RNA interference for treatment and prevention of cancer
#150Methods and compositions for enhancing the therapeutic effect of anti-tumor T cells
#151Control of gene expression
#152Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
#153Production and extraction of MicroRNA precursor as drug for cancer therapy
#154Differentially expressed microRNA molecules for the treatment and diagnosis of cancer
#155Production and utilization of a novel anti-cancer drug in therapy
#156MOLECULAR TARGETS FOR HEALING OR TREATING WOUNDS
#157CONTROL OF GENE EXPRESSION
#158Single molecule nucleic acid nanoparticles
#159ANTIPROLIFERATIVE AGENT
#160Interleukin-1 Alpha Antibodies and Methods of Use
#161Method and system for monitoring nutritional uptake as a function of microflora intestinal gas levels
#162MULTIPLE RNA POLYMERASE III PROMOTER EXPRESSION CONSTRUCTS
#163Interleukin-1 Alpha Antibodies and Methods of Use
#164Interleukin-1 alpha antibodies and methods of use
#165Interleukin-1α antibodies and methods of use
#166Interleukin-1 alpha antibodies and methods of use
#167CHEMOSENSITIZATION BY BI-FUNCTIONAL SMALL HAIRPIN RNA (bi-shRNA)
#168CATEGORIZATION OF MICROBIAL COMMUNITIES
#169Categorization of Microbial Communities
#170Multiple RNA polymerase III promoter expression constructs
#171Interleukin-1α antibodies
#172ANTI-NOTCH1 NRR ANTIBODIES AND METHODS USING SAME
#173Methods to enhance the stability and homogeneity of transgene expression in clonal cell lines
#174Anti-Notch1 NRR antibodies
#175Inhibiting Gene Expression with dsRNA
#176Inhibiting Gene Expression with dsRNA
#177Self-Processing Rna Expression Cassette
#178Single-stranded antimicrobial oligonucleotides and uses thereof
#179Double-stranded and single-stranded RNA molecules with 5′ triphosphates and their use for inducing interferon
#180Double-stranded and single-stranded RNA molecules with 5 ' triphosphates and their use for inducing interferon
#181Categorization of microbial communities
#182Control of gene expression
#183Methods for making recombinant proteins
#184Recombinant microorganisms for conversion of oligosaccharides into functional sweeteners
#185Methods for making recombinant proteins